APO Research
Talk to an analyst

APO RESEARCH · REPORT

Diagnostic Radiopharmaceuticals

Radiopharmaceuticals refer to a class of special medicines containing radionuclides for medical diagnosis and treatment. Compounds or biological preparations containing radionuclide labels used for medical diagnosis or treatment in the body. Diagnostic radiopharmaceuticals are radioisotopes that bind to biomolecules that can locate specific organs, tissues or cells in the body. These radiopharmaceuticals can be used to diagnose diseases.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Radiopharmaceuticals refer to a class of special medicines containing radionuclides for medical diagnosis and treatment. Compounds or biological preparations containing radionuclide labels used for medical diagnosis or treatment in the body. Diagnostic radiopharmaceuticals are radioisotopes that bind to biomolecules that can locate specific organs, tissues or cells in the body. These radiopharmaceuticals can be used to diagnose diseases.

Selected research

Market Outlook & Growth Opportunities

Global Diagnostic Radiopharmaceuticals Market Outlook and Growth Opportunities 2026

30 December 2025194 pages

Choose your research edition.

Industry ResearchDiagnostic Radiopharmaceuticals Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Diagnostic Radiopharmaceuticals Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Diagnostic Radiopharmaceuticals Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Diagnostic Radiopharmaceuticals Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Diagnostic Radiopharmaceuticals Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Radiopharmaceuticals refer to a class of special medicines containing radionuclides for medical diagnosis and treatment. Compounds or biological preparations containing radionuclide labels used for medical diagnosis or treatment in the body. Diagnostic radiopharmaceuticals are radioisotopes that bind to biomolecules that can locate specific organs, tissues or cells in the body. These radiopharmaceuticals can be used to diagnose diseases.

North America is the world's major consumer region, with sales accounting for 41.59% of the global total in 2019. Europe is also a major consumer region, accounting for 24.5% of the global market. China is also a very important consumer region due to the large number of cancers. At present, products represented by Cardinal Health, GE Healthcare, Curium Pharma, Jubilant Pharma, Bracco Imaging, etc. occupy a major position in the global market.

This report provides an overview of the global Diagnostic Radiopharmaceuticals market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Diagnostic Radiopharmaceuticals and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Diagnostic Radiopharmaceuticals sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Diagnostic Radiopharmaceuticals market size, projected growth trends, production technologies, key applications, and end-use industries.

Diagnostic Radiopharmaceuticals Segment by Company

Cardinal Health

GE Healthcare

Curium Pharma

Jubilant Pharma

Bracco Imaging

Advanced Accelerator Applications

SIEMENS

China Isotope & Radiation

Dongcheng Pharmaceutical Group

Lantheus

Eli Lilly

Diagnostic Radiopharmaceuticals Segment by Type

Technetium 99

Fluorine 18

Other

Diagnostic Radiopharmaceuticals Segment by Application

Oncology

Cardiology

Other

Diagnostic Radiopharmaceuticals Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Diagnostic Radiopharmaceuticals status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Diagnostic Radiopharmaceuticals market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Diagnostic Radiopharmaceuticals significant trends, drivers, influence factors in global and regions.

6. To analyze Diagnostic Radiopharmaceuticals competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diagnostic Radiopharmaceuticals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Diagnostic Radiopharmaceuticals and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diagnostic Radiopharmaceuticals.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Diagnostic Radiopharmaceuticals market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Diagnostic Radiopharmaceuticals industry.

Chapter 3: Detailed analysis of Diagnostic Radiopharmaceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Diagnostic Radiopharmaceuticals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Diagnostic Radiopharmaceuticals in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Diagnostic Radiopharmaceuticals Industry Trends Table 2. Diagnostic Radiopharmaceuticals Industry Drivers Table 3. Diagnostic Radiopharmaceuticals Industry Opportunities and Challenges Table 4. Diagnostic Radiopharmaceuticals Industry Restraints Table 5. Global Diagnostic Radiopharmaceuticals Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Diagnostic Radiopharmaceuticals Revenue Share by Company (2021-2026) Table 7. Global Diagnostic Radiopharmaceuticals Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Diagnostic Radiopharmaceuticals Sales Volume Share by Company (2021-2026) Table 9. Global Diagnostic Radiopharmaceuticals Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Diagnostic Radiopharmaceuticals Company Ranking, (2024-2026) & (USD Million) Table 11. Global Diagnostic Radiopharmaceuticals Key Company Manufacturing Base & Headquarters Table 12. Global Diagnostic Radiopharmaceuticals Company, Product Type & Application Table 13. Global Diagnostic Radiopharmaceuticals Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Diagnostic Radiopharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Technetium 99 Table 18. Significant Companies of Fluorine 18 Table 19. Significant Companies of Other Table 20. Global Diagnostic Radiopharmaceuticals Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Diagnostic Radiopharmaceuticals Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Diagnostic Radiopharmaceuticals Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Diagnostic Radiopharmaceuticals Sales Volume Share by Type (2021-2026) Table 24. Global Diagnostic Radiopharmaceuticals Sales Volume Share by Type (2027-2032) Table 25. Global Diagnostic Radiopharmaceuticals Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Diagnostic Radiopharmaceuticals Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Diagnostic Radiopharmaceuticals Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Diagnostic Radiopharmaceuticals Sales Value Share by Type (2021-2026) Table 29. Global Diagnostic Radiopharmaceuticals Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Oncology Table 31. Significant Companies of Cardiology Table 32. Significant Companies of Other Table 33. Global Diagnostic Radiopharmaceuticals Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Diagnostic Radiopharmaceuticals Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Diagnostic Radiopharmaceuticals Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Diagnostic Radiopharmaceuticals Sales Volume Share by Application (2021-2026) Table 37. Global Diagnostic Radiopharmaceuticals Sales Volume Share by Application (2027-2032) Table 38. Global Diagnostic Radiopharmaceuticals Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Diagnostic Radiopharmaceuticals Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Diagnostic Radiopharmaceuticals Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Diagnostic Radiopharmaceuticals Sales Value Share by Application (2021-2026) Table 42. Global Diagnostic Radiopharmaceuticals Sales Value Share by Application (2027-2032) Table 43. Global Diagnostic Radiopharmaceuticals Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Diagnostic Radiopharmaceuticals Sales by Region (2021-2026) & (K Units) Table 45. Global Diagnostic Radiopharmaceuticals Sales Market Share by Region (2021-2026) Table 46. Global Diagnostic Radiopharmaceuticals Sales by Region (2027-2032) & (K Units) Table 47. Global Diagnostic Radiopharmaceuticals Sales Market Share by Region (2027-2032) Table 48. Global Diagnostic Radiopharmaceuticals Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Diagnostic Radiopharmaceuticals Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Diagnostic Radiopharmaceuticals Sales Value Share by Region (2021-2026) Table 51. Global Diagnostic Radiopharmaceuticals Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Diagnostic Radiopharmaceuticals Sales Value Share by Region (2027-2032) Table 53. Global Diagnostic Radiopharmaceuticals Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Diagnostic Radiopharmaceuticals Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Diagnostic Radiopharmaceuticals Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Diagnostic Radiopharmaceuticals Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Diagnostic Radiopharmaceuticals Sales by Country (2021-2026) & (K Units) Table 58. Global Diagnostic Radiopharmaceuticals Sales Market Share by Country (2021-2026) Table 59. Global Diagnostic Radiopharmaceuticals Sales by Country (2027-2032) & (K Units) Table 60. Global Diagnostic Radiopharmaceuticals Sales Market Share by Country (2027-2032) Table 61. Global Diagnostic Radiopharmaceuticals Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Diagnostic Radiopharmaceuticals Sales Value Market Share by Country (2021-2026) Table 63. Global Diagnostic Radiopharmaceuticals Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Diagnostic Radiopharmaceuticals Sales Value Market Share by Country (2027-2032) Table 65. Cardinal Health Company Information Table 66. Cardinal Health Business Overview Table 67. Cardinal Health Diagnostic Radiopharmaceuticals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Cardinal Health Diagnostic Radiopharmaceuticals Product Portfolio Table 69. Cardinal Health Recent Development Table 70. GE Healthcare Company Information Table 71. GE Healthcare Business Overview Table 72. GE Healthcare Diagnostic Radiopharmaceuticals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. GE Healthcare Diagnostic Radiopharmaceuticals Product Portfolio Table 74. GE Healthcare Recent Development Table 75. Curium Pharma Company Information Table 76. Curium Pharma Business Overview Table 77. Curium Pharma Diagnostic Radiopharmaceuticals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Curium Pharma Diagnostic Radiopharmaceuticals Product Portfolio Table 79. Curium Pharma Recent Development Table 80. Jubilant Pharma Company Information Table 81. Jubilant Pharma Business Overview Table 82. Jubilant Pharma Diagnostic Radiopharmaceuticals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Jubilant Pharma Diagnostic Radiopharmaceuticals Product Portfolio Table 84. Jubilant Pharma Recent Development Table 85. Bracco Imaging Company Information Table 86. Bracco Imaging Business Overview Table 87. Bracco Imaging Diagnostic Radiopharmaceuticals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Bracco Imaging Diagnostic Radiopharmaceuticals Product Portfolio Table 89. Bracco Imaging Recent Development Table 90. Advanced Accelerator Applications Company Information Table 91. Advanced Accelerator Applications Business Overview Table 92. Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Product Portfolio Table 94. Advanced Accelerator Applications Recent Development Table 95. SIEMENS Company Information Table 96. SIEMENS Business Overview Table 97. SIEMENS Diagnostic Radiopharmaceuticals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. SIEMENS Diagnostic Radiopharmaceuticals Product Portfolio Table 99. SIEMENS Recent Development Table 100. China Isotope & Radiation Company Information Table 101. China Isotope & Radiation Business Overview Table 102. China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. China Isotope & Radiation Diagnostic Radiopharmaceuticals Product Portfolio Table 104. China Isotope & Radiation Recent Development Table 105. Dongcheng Pharmaceutical Group Company Information Table 106. Dongcheng Pharmaceutical Group Business Overview Table 107. Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Product Portfolio Table 109. Dongcheng Pharmaceutical Group Recent Development Table 110. Lantheus Company Information Table 111. Lantheus Business Overview Table 112. Lantheus Diagnostic Radiopharmaceuticals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Lantheus Diagnostic Radiopharmaceuticals Product Portfolio Table 114. Lantheus Recent Development Table 115. Eli Lilly Company Information Table 116. Eli Lilly Business Overview Table 117. Eli Lilly Diagnostic Radiopharmaceuticals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Eli Lilly Diagnostic Radiopharmaceuticals Product Portfolio Table 119. Eli Lilly Recent Development Table 120. Key Raw Materials Table 121. Raw Materials Key Suppliers Table 122. Diagnostic Radiopharmaceuticals Distributors List Table 123. Diagnostic Radiopharmaceuticals Customers List Table 124. Research Programs/Design for This Report Table 125. Authors List of This Report Table 126. Secondary Sources Table 127. Primary Sources List of Figures Figure 1. Diagnostic Radiopharmaceuticals Product Image Figure 2. Global Diagnostic Radiopharmaceuticals Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Diagnostic Radiopharmaceuticals Sales Value (2021-2032) & (US$ Million) Figure 4. Global Diagnostic Radiopharmaceuticals Sales (2021-2032) & (K Units) Figure 5. Global Diagnostic Radiopharmaceuticals Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Diagnostic Radiopharmaceuticals Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Technetium 99 Image Figure 10. Fluorine 18 Image Figure 11. Other Image Figure 12. Global Diagnostic Radiopharmaceuticals Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Diagnostic Radiopharmaceuticals Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Diagnostic Radiopharmaceuticals Sales Volume Share by Type (2021-2032) Figure 15. Global Diagnostic Radiopharmaceuticals Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Diagnostic Radiopharmaceuticals Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Diagnostic Radiopharmaceuticals Sales Value Share by Type (2021-2032) Figure 18. Oncology Image Figure 19. Cardiology Image Figure 20. Other Image Figure 21. Global Diagnostic Radiopharmaceuticals Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Diagnostic Radiopharmaceuticals Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Diagnostic Radiopharmaceuticals Sales Volume Share by Application (2021-2032) Figure 24. Global Diagnostic Radiopharmaceuticals Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Diagnostic Radiopharmaceuticals Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Diagnostic Radiopharmaceuticals Sales Value Share by Application (2021-2032) Figure 27. Global Diagnostic Radiopharmaceuticals Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Diagnostic Radiopharmaceuticals Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Diagnostic Radiopharmaceuticals Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Diagnostic Radiopharmaceuticals Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Diagnostic Radiopharmaceuticals Sales Value (2021-2032) & (US$ Million) Figure 32. North America Diagnostic Radiopharmaceuticals Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Diagnostic Radiopharmaceuticals Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Diagnostic Radiopharmaceuticals Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Diagnostic Radiopharmaceuticals Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Diagnostic Radiopharmaceuticals Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Diagnostic Radiopharmaceuticals Sales Value (2021-2032) & (US$ Million) Figure 38. South America Diagnostic Radiopharmaceuticals Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Diagnostic Radiopharmaceuticals Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Diagnostic Radiopharmaceuticals Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Diagnostic Radiopharmaceuticals Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Diagnostic Radiopharmaceuticals Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Technetium 99
  • Fluorine 18
  • Other
Applications
  • Oncology
  • Cardiology
  • Other
Companies covered
  • Cardinal Health
  • GE Healthcare
  • Curium Pharma
  • Jubilant Pharma
  • Bracco Imaging
  • Advanced Accelerator Applications
  • SIEMENS
  • China Isotope & Radiation
  • Dongcheng Pharmaceutical Group
  • Lantheus
  • Eli Lilly

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Diagnostic Radiopharmaceuticals Sales Value (2021-2032)
  4. 1.2.2 Global Diagnostic Radiopharmaceuticals Sales Volume (2021-2032)
  5. 1.2.3 Global Diagnostic Radiopharmaceuticals Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Diagnostic Radiopharmaceuticals Market Dynamics
  1. 2.1 Diagnostic Radiopharmaceuticals Industry Trends
  2. 2.2 Diagnostic Radiopharmaceuticals Industry Drivers
  3. 2.3 Diagnostic Radiopharmaceuticals Industry Opportunities and Challenges
  4. 2.4 Diagnostic Radiopharmaceuticals Industry Restraints
3 Diagnostic Radiopharmaceuticals Market by Company
  1. 3.1 Global Diagnostic Radiopharmaceuticals Company Revenue Ranking in 2025
  2. 3.2 Global Diagnostic Radiopharmaceuticals Revenue by Company (2021-2026)
  3. 3.3 Global Diagnostic Radiopharmaceuticals Sales Volume by Company (2021-2026)
  4. 3.4 Global Diagnostic Radiopharmaceuticals Average Price by Company (2021-2026)
  5. 3.5 Global Diagnostic Radiopharmaceuticals Company Ranking (2024-2026)
  6. 3.6 Global Diagnostic Radiopharmaceuticals Company Manufacturing Base and Headquarters
  7. 3.7 Global Diagnostic Radiopharmaceuticals Company Product Type and Application
  8. 3.8 Global Diagnostic Radiopharmaceuticals Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Diagnostic Radiopharmaceuticals Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Diagnostic Radiopharmaceuticals Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Diagnostic Radiopharmaceuticals Market by Type
  1. 4.1 Diagnostic Radiopharmaceuticals Type Introduction
  2. 4.1.1 Technetium 99
  3. 4.1.2 Fluorine 18
  4. 4.1.3 Other
  5. 4.2 Global Diagnostic Radiopharmaceuticals Sales Volume by Type
  6. 4.2.1 Global Diagnostic Radiopharmaceuticals Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Diagnostic Radiopharmaceuticals Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Diagnostic Radiopharmaceuticals Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Diagnostic Radiopharmaceuticals Sales Value by Type
  10. 4.3.1 Global Diagnostic Radiopharmaceuticals Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Diagnostic Radiopharmaceuticals Sales Value by Type (2021-2032)
  12. 4.3.3 Global Diagnostic Radiopharmaceuticals Sales Value Share by Type (2021-2032)
5 Diagnostic Radiopharmaceuticals Market by Application
  1. 5.1 Diagnostic Radiopharmaceuticals Application Introduction
  2. 5.1.1 Oncology
  3. 5.1.2 Cardiology
  4. 5.1.3 Other
  5. 5.2 Global Diagnostic Radiopharmaceuticals Sales Volume by Application
  6. 5.2.1 Global Diagnostic Radiopharmaceuticals Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Diagnostic Radiopharmaceuticals Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Diagnostic Radiopharmaceuticals Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Diagnostic Radiopharmaceuticals Sales Value by Application
  10. 5.3.1 Global Diagnostic Radiopharmaceuticals Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Diagnostic Radiopharmaceuticals Sales Value by Application (2021-2032)
  12. 5.3.3 Global Diagnostic Radiopharmaceuticals Sales Value Share by Application (2021-2032)
6 Diagnostic Radiopharmaceuticals Regional Sales and Value Analysis
  1. 6.1 Global Diagnostic Radiopharmaceuticals Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Diagnostic Radiopharmaceuticals Sales by Region (2021-2032)
  3. 6.2.1 Global Diagnostic Radiopharmaceuticals Sales by Region: 2021-2026
  4. 6.2.2 Global Diagnostic Radiopharmaceuticals Sales by Region (2027-2032)
  5. 6.3 Global Diagnostic Radiopharmaceuticals Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Diagnostic Radiopharmaceuticals Sales Value by Region (2021-2032)
  7. 6.4.1 Global Diagnostic Radiopharmaceuticals Sales Value by Region: 2021-2026
  8. 6.4.2 Global Diagnostic Radiopharmaceuticals Sales Value by Region (2027-2032)
  9. 6.5 Global Diagnostic Radiopharmaceuticals Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Diagnostic Radiopharmaceuticals Sales Value (2021-2032)
  12. 6.6.2 North America Diagnostic Radiopharmaceuticals Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Diagnostic Radiopharmaceuticals Sales Value (2021-2032)
  15. 6.7.2 Europe Diagnostic Radiopharmaceuticals Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Diagnostic Radiopharmaceuticals Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Diagnostic Radiopharmaceuticals Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Diagnostic Radiopharmaceuticals Sales Value (2021-2032)
  21. 6.9.2 South America Diagnostic Radiopharmaceuticals Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Diagnostic Radiopharmaceuticals Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Diagnostic Radiopharmaceuticals Sales Value Share by Country, 2025 VS 2032
7 Diagnostic Radiopharmaceuticals Country-level Sales and Value Analysis
  1. 7.1 Global Diagnostic Radiopharmaceuticals Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Diagnostic Radiopharmaceuticals Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Diagnostic Radiopharmaceuticals Sales by Country (2021-2032)
  4. 7.3.1 Global Diagnostic Radiopharmaceuticals Sales by Country (2021-2026)
  5. 7.3.2 Global Diagnostic Radiopharmaceuticals Sales by Country (2027-2032)
  6. 7.4 Global Diagnostic Radiopharmaceuticals Sales Value by Country (2021-2032)
  7. 7.4.1 Global Diagnostic Radiopharmaceuticals Sales Value by Country (2021-2026)
  8. 7.4.2 Global Diagnostic Radiopharmaceuticals Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Diagnostic Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Diagnostic Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Diagnostic Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Cardinal Health
  2. 8.1.1 Cardinal Health Company Information
  3. 8.1.2 Cardinal Health Business Overview
  4. 8.1.3 Cardinal Health Diagnostic Radiopharmaceuticals Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Cardinal Health Diagnostic Radiopharmaceuticals Product Portfolio
  6. 8.1.5 Cardinal Health Recent Developments
  7. 8.2 GE Healthcare
  8. 8.2.1 GE Healthcare Company Information
  9. 8.2.2 GE Healthcare Business Overview
  10. 8.2.3 GE Healthcare Diagnostic Radiopharmaceuticals Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 GE Healthcare Diagnostic Radiopharmaceuticals Product Portfolio
  12. 8.2.5 GE Healthcare Recent Developments
  13. 8.3 Curium Pharma
  14. 8.3.1 Curium Pharma Company Information
  15. 8.3.2 Curium Pharma Business Overview
  16. 8.3.3 Curium Pharma Diagnostic Radiopharmaceuticals Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Curium Pharma Diagnostic Radiopharmaceuticals Product Portfolio
  18. 8.3.5 Curium Pharma Recent Developments
  19. 8.4 Jubilant Pharma
  20. 8.4.1 Jubilant Pharma Company Information
  21. 8.4.2 Jubilant Pharma Business Overview
  22. 8.4.3 Jubilant Pharma Diagnostic Radiopharmaceuticals Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Jubilant Pharma Diagnostic Radiopharmaceuticals Product Portfolio
  24. 8.4.5 Jubilant Pharma Recent Developments
  25. 8.5 Bracco Imaging
  26. 8.5.1 Bracco Imaging Company Information
  27. 8.5.2 Bracco Imaging Business Overview
  28. 8.5.3 Bracco Imaging Diagnostic Radiopharmaceuticals Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Bracco Imaging Diagnostic Radiopharmaceuticals Product Portfolio
  30. 8.5.5 Bracco Imaging Recent Developments
  31. 8.6 Advanced Accelerator Applications
  32. 8.6.1 Advanced Accelerator Applications Company Information
  33. 8.6.2 Advanced Accelerator Applications Business Overview
  34. 8.6.3 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Product Portfolio
  36. 8.6.5 Advanced Accelerator Applications Recent Developments
  37. 8.7 SIEMENS
  38. 8.7.1 SIEMENS Company Information
  39. 8.7.2 SIEMENS Business Overview
  40. 8.7.3 SIEMENS Diagnostic Radiopharmaceuticals Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 SIEMENS Diagnostic Radiopharmaceuticals Product Portfolio
  42. 8.7.5 SIEMENS Recent Developments
  43. 8.8 China Isotope & Radiation
  44. 8.8.1 China Isotope & Radiation Company Information
  45. 8.8.2 China Isotope & Radiation Business Overview
  46. 8.8.3 China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 China Isotope & Radiation Diagnostic Radiopharmaceuticals Product Portfolio
  48. 8.8.5 China Isotope & Radiation Recent Developments
  49. 8.9 Dongcheng Pharmaceutical Group
  50. 8.9.1 Dongcheng Pharmaceutical Group Company Information
  51. 8.9.2 Dongcheng Pharmaceutical Group Business Overview
  52. 8.9.3 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Product Portfolio
  54. 8.9.5 Dongcheng Pharmaceutical Group Recent Developments
  55. 8.10 Lantheus
  56. 8.10.1 Lantheus Company Information
  57. 8.10.2 Lantheus Business Overview
  58. 8.10.3 Lantheus Diagnostic Radiopharmaceuticals Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Lantheus Diagnostic Radiopharmaceuticals Product Portfolio
  60. 8.10.5 Lantheus Recent Developments
  61. 8.11 Eli Lilly
  62. 8.11.1 Eli Lilly Company Information
  63. 8.11.2 Eli Lilly Business Overview
  64. 8.11.3 Eli Lilly Diagnostic Radiopharmaceuticals Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Eli Lilly Diagnostic Radiopharmaceuticals Product Portfolio
  66. 8.11.5 Eli Lilly Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Diagnostic Radiopharmaceuticals Value Chain Analysis
  2. 9.1.1 Diagnostic Radiopharmaceuticals Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Diagnostic Radiopharmaceuticals Sales Mode & Process
  6. 9.2 Diagnostic Radiopharmaceuticals Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Diagnostic Radiopharmaceuticals Distributors
  9. 9.2.3 Diagnostic Radiopharmaceuticals Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst